|
Dementia degenerative
|
n = 65 (32.8%)
|
n = 97 (37.2%)
|
|
vascular
|
n = 57 (28.8%)
|
n = 80 (30.6%)
|
|
Congenital
|
n = 11 (5.6%)
|
n = 8 (3.1%)
|
|
Toxic (hepatic, uremic, ethylic.)
|
n = 7 (3.5%)
|
n = 14 (5.4%)
|
|
Inflammatory (status post.)
|
n = 5 (2,5%)
|
n = 5 (1.9%)
|
|
Epileptic
|
n = 4 (2%)
|
n = 8 (3.1%)
|
|
Posttraumatic
|
n = 4 (2%)
|
n = 7 (2.7%)
|
|
Joints and vertebra
|
N = 84 (42.4%)
|
N = 168 (64.4%)
|
|
Degenerative
|
n = 71 (35.8%)
|
n = 153 (58.6%)
|
|
Posttraumatic
|
n = 11 (5.6%)
|
n = 25 (9.6%)
|
|
Inflammatory (status post)
|
n = 6 (3.0%)
|
n = 24 (9.2%)
|
|
Congenital
|
n = 3 (1.5%)
|
n = 5 (1.9%)
|
|
Cardiorespiratory and vascular system
|
N = 78 (39.4%)
|
N = 102 (39%)
|
|
Coronary heart disease and chronic heart failure
|
n = 70 (35.4%)
|
n = 84 (32.2%)
|
|
COPD und asthma
|
n = 11 (5.6%)
|
n = 30 (11.5%)
|
|
Peripheral arterial occlusive disease
|
n = 8 (4.0%)
|
n = 29 (11.1%)
|
|
Metabolic diseases
|
N = 30 (15.2%)
|
N = 60 (23.0%)
|
|
Diabetes
|
n = 22 (11,1%)
|
n = 49 (18.8%)
|
|
Hepatic
|
n = 6 (3.0%)
|
n = 10 (3.8%)
|
|
Renal
|
n = 7 (3.5%)
|
n = 7 (2.7%)
|
|
Other diseases
|
N = 64 (32.3%)
|
N = 63 (24.1%)
|
|
Marasmus senilis
|
n = 38 (19.2%)
|
n = 25(9.6%)
|
|
Blindness
|
n = 14 (7.1%)
|
n = 25 (9.6%)
|
|
Deafness
|
n = 14 (7.1%)
|
n = 18 (6.9%)
|
|
Terminal malignant disease
|
n = 10 (5.1%)
|
n = 11 (4.2%)
|
